Funded Biotechnology Startups in South Korea
LegoChem Biosciences’ $214M (2026-06-26) is the largest disclosed biotech round in this South Korea slice, and it stands out as an outlier versus the rest…
LegoChem Biosciences’ $214M (2026-06-26) is the largest disclosed biotech round in this South Korea slice, and it stands out as an outlier versus the rest of the disclosed amounts, where the next tier is $124M (April Bio, 2026-06-25) followed by several mid-single to low-double-digit millions (e.g., Spark Biopharma $21M on 2026-05-11; LabGenomics $13M on 2026-06-08). The segment is time-clustered: all 12 entries fall between 2026-04-07 and 2026-07-13, with most disclosed rounds concentrated in May–June 2026.
Geographically, Seoul appears most frequently (6 entries), paired with Daejeon (2 entries), suggesting a Seoul-heavy pattern for these recent rounds. Stage naming is also concentrated in classification gaps: of the 12 rows, 10 are disclosed and 2 are undisclosed, and 9 of the 12 entries are labeled “Series Unknown” (including several of the Seoul-based companies such as Cureverse, Spark Biopharma, and SN BioScience).
Most recent rounds
12 shownRelated listings
Frequently asked
What is the largest disclosed biotech round here, and how far above the rest is it?
LegoChem Biosciences’ disclosed $214M (2026-06-26) is the top figure; the next-largest disclosed round is April Bio’s $124M (2026-06-25). After that, the disclosed amounts drop into a lower range (e.g., Spark Biopharma $21M on 2026-05-11; LabGenomics $13M on 2026-06-08).
Do the most recent closings cluster into a narrow window?
Yes. The displayed rounds span 2026-04-07 to 2026-07-13, and the majority of disclosed amounts fall in May–June 2026 (for example, Spark Biopharma $21M on 2026-05-11 and ArcGen Bioscience $7M on 2026-07-13).
Which cities are over-represented among these 12 entries?
Seoul is the main concentration with 6 of the 12 rows (e.g., ADEL $2M on 2026-06-11; Shaperon $6M on 2026-04-09), while Daejeon accounts for 2 entries (ArcGen Bioscience in Daejeon on 2026-07-13 and LegoChem Biosciences in Daejeon on 2026-06-26).
How dominant is “Series Unknown” compared with named stages like Seed or Series A?
“Series Unknown” appears on 9 of the 12 rows. Named stages are limited: ArcGen Bioscience is labeled Series A with $7M (2026-07-13), and Jeju Salt is labeled Seed with undisclosed funding (2026-04-22).
Are there notable outliers on disclosed size, including the smallest disclosed amount?
Cureverse is the smallest disclosed figure at $990K (2026-05-21), while the largest disclosed round is LegoChem Biosciences at $214M (2026-06-26). That spread is large compared with other disclosed entries clustered in the $6M–$21M range (e.g., Shaperon $6M on 2026-04-09; SN BioScience $9M on 2026-04-07).
Which entries are undisclosed, and do they align with the largest-city pattern (Seoul)?
Two entries are undisclosed: Jeju Salt (Seed, Jeju, 2026-04-22) and ROKIT Healthcare (Series Unknown, Seoul, 2026-04-13). With one undisclosed round in Seoul, the Seoul-heavy pattern still holds, but the undisclosed data isn’t concentrated exclusively in the top city.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.